{"id":22171,"date":"2026-01-21T09:33:48","date_gmt":"2026-01-21T17:33:48","guid":{"rendered":"https:\/\/drugpolicy.ca\/les-problemes\/reduction-des-mefaits\/"},"modified":"2026-01-21T09:33:48","modified_gmt":"2026-01-21T17:33:48","slug":"reduction-des-mefaits","status":"publish","type":"page","link":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/","title":{"rendered":"R\u00e9duction des m\u00e9faits"},"content":{"rendered":"\n<div class=\"wp-block-group alignwide is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-794e3cfa wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:60%\">\n<p class=\"wp-block-paragraph\">La r\u00e9duction des m\u00e9faits permet de sauver des vies et de mettre les gens en contact avec un soutien social vital, des services et des traitements fond\u00e9s sur des donn\u00e9es probantes.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:40%\"><\/div>\n<\/div>\n<\/div>\n<figure style=\"aspect-ratio:21\/9; margin-top:var(--wp--preset--spacing--50);margin-bottom:var(--wp--preset--spacing--60);\" class=\"alignwide wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"800\" src=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Une salle avec des stalles individuelles\" style=\"width:100%;height:100%;object-fit:cover;\" srcset=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg 1200w, https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1-300x200.jpg 300w, https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1-1024x683.jpg 1024w, https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1-768x512.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n<div class=\"wp-block-group has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\" style=\"margin-top:var(--wp--preset--spacing--50);margin-bottom:var(--wp--preset--spacing--50)\">\n<h2 class=\"wp-block-heading\"><strong>Qu&#8217;est-ce que la r\u00e9duction des m\u00e9faits ?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La r\u00e9duction des risques est une approche philosophique de la consommation de drogues. Elle reconna\u00eet la complexit\u00e9 de la consommation de drogues et les avantages et les risques qu&#8217;elle comporte, tout en admettant qu&#8217;une grande partie des m\u00e9faits sont le r\u00e9sultat de lois, de syst\u00e8mes et d&#8217;institutions obsol\u00e8tes.   <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Elle permet aux individus de vivre une vie plus s\u00fbre et plus saine en donnant la priorit\u00e9 au choix individuel, \u00e0 l&#8217;autonomie et au bien-\u00eatre, ind\u00e9pendamment de la consommation de drogues, sans porter de jugement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les programmes de r\u00e9duction des m\u00e9faits, tels que les sites de pr\u00e9vention des overdoses, la mise \u00e0 disposition de mat\u00e9riel de consommation de drogues et la distribution de naloxone, mettent les personnes qui consomment des drogues en contact avec une s\u00e9rie de services de sant\u00e9 et de soutien social.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Elle englobe une s\u00e9rie de strat\u00e9gies et de politiques pratiques qui r\u00e9duisent les risques individuels, la consommation publique de m\u00e9dicaments, ainsi que les charges et les co\u00fbts des syst\u00e8mes de sant\u00e9.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En mars 2024, pour la premi\u00e8re fois, une r\u00e9solution de la Commission des stup\u00e9fiants inclura le terme &#8220;r\u00e9duction des m\u00e9faits&#8221; &#8211; un changement significatif au niveau international, indiquant une compr\u00e9hension croissante de cette approche philosophique.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Priorit\u00e9s d&#8217;action<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Les gouvernements provinciaux doivent cesser d&#8217;entraver les sites d&#8217;overdose et de consommation supervis\u00e9e.  <\/li>\n\n\n\n<li>Sites d&#8217;inhalation supervis\u00e9s.<\/li>\n\n\n\n<li>D\u00e9velopper les services de r\u00e9duction des risques dans les prisons.  <\/li>\n\n\n\n<li>Soutien dans les r\u00e9gions \u00e9loign\u00e9es et rurales.<\/li>\n\n\n\n<li>Fourniture d&#8217;alternatives m\u00e9dicamenteuses r\u00e9glement\u00e9es \u00e0 l&#8217;offre de drogues illicites non r\u00e9glement\u00e9es.<\/li>\n\n\n\n<li>\u00c9largir la distribution de naloxone et le contr\u00f4le des drogues.  <\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Pour en savoir plus<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"http:\/\/www.health.gov.bc.ca\/library\/publications\/year\/2005\/hrcommunityguide.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">R\u00e9duction des m\u00e9faits : Guide \u00e0 l&#8217;intention des communaut\u00e9s de la Colombie-Britannique<\/a><\/li>\n\n\n\n<li><a href=\"http:\/\/www.ihra.net\/\" target=\"_blank\" rel=\"noreferrer noopener\">Harm Reduction International<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/towardtheheart.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Centre de contr\u00f4le des maladies de la Colombie-Britannique<\/a><\/li>\n\n\n\n<li><a href=\"http:\/\/www.catie.ca\/en\/programming\/best-practices-harm-reduction\" target=\"_blank\" rel=\"noreferrer noopener\">CATIE<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/supervised-consumption-sites\/status-application.html\" target=\"_blank\" rel=\"noreferrer noopener\">Demande de site de consommation supervis\u00e9e<\/a><\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-35f06ea7 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\">Demande de site de consommation supervis\u00e9e<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:var(--wp--preset--spacing--60)\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La r\u00e9duction des m\u00e9faits permet de sauver des vies et de mettre les gens en contact avec un soutien social vital, des services et des traitements fond\u00e9s sur des donn\u00e9es probantes. Qu&#8217;est-ce que la r\u00e9duction des m\u00e9faits ? La r\u00e9duction des risques est une approche philosophique de la consommation de drogues. Elle reconna\u00eet la complexit\u00e9 [&hellip;]<\/p>\n","protected":false},"author":53,"featured_media":8805,"parent":22088,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"class_list":["post-22171","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"La r\u00e9duction des m\u00e9faits permet de sauver des vies et de mettre les gens en contact avec un soutien social vital, des services et des traitements fond\u00e9s sur des donn\u00e9es probantes. Qu&#8217;est-ce que la r\u00e9duction des m\u00e9faits ? La r\u00e9duction des risques est une approche philosophique de la consommation de drogues. Elle reconna\u00eet la complexit\u00e9 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/\",\"name\":\"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Turning-Point-OPS-1.jpg\",\"datePublished\":\"2026-01-21T17:33:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Turning-Point-OPS-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Turning-Point-OPS-1.jpg\",\"width\":1200,\"height\":800,\"caption\":\"Turning Point overdose prevention site | Red Deer, AB | n.d.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/les-problemes\\\/reduction-des-mefaits\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mail.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les probl\u00e8mes\",\"item\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/les-problemes\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"R\u00e9duction des m\u00e9faits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","og_description":"La r\u00e9duction des m\u00e9faits permet de sauver des vies et de mettre les gens en contact avec un soutien social vital, des services et des traitements fond\u00e9s sur des donn\u00e9es probantes. Qu&#8217;est-ce que la r\u00e9duction des m\u00e9faits ? La r\u00e9duction des risques est une approche philosophique de la consommation de drogues. Elle reconna\u00eet la complexit\u00e9 [&hellip;]","og_url":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/","og_site_name":"Canadian Drug Policy Coalition","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/","url":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/","name":"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/#primaryimage"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg","datePublished":"2026-01-21T17:33:48+00:00","breadcrumb":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/#primaryimage","url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg","contentUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg","width":1200,"height":800,"caption":"Turning Point overdose prevention site | Red Deer, AB | n.d."},{"@type":"BreadcrumbList","@id":"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mail.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Les probl\u00e8mes","item":"https:\/\/drugpolicy.ca\/fr\/les-problemes\/"},{"@type":"ListItem","position":3,"name":"R\u00e9duction des m\u00e9faits"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/pages\/22171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/53"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=22171"}],"version-history":[{"count":1,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/pages\/22171\/revisions"}],"predecessor-version":[{"id":22172,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/pages\/22171\/revisions\/22172"}],"up":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/pages\/22088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/8805"}],"wp:attachment":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=22171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}